ClinicalTrials.gg
Sign In

Ear Diseases clinical trials

The registry lists 48 studies for Ear Diseases across more than 10 countries. 10 are recruiting or about to start. 11 of them are mainly about Ear Diseases (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-10. Counting its 32 narrower conditions too, such as Hearing Loss: 2,796 studies, 628 open.

Get an email when these change. Save the Ear Diseases studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
26
Recruiting
6
Terminated
4
Status unknown
4
Not yet recruiting
3
Active, not recruiting
2

Phase

Phase 2
8
Phase 1
4
Phase 3
3
Phase 4
2

Where

United States
17
Canada
6
France
5
Israel
3
Denmark
3
Germany
3

Who runs them

Advanced Bionics (7) · Oticon Medical (4) · Otic Pharma (3) · Sunnybrook Health Sciences Centre (2) · Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University (2) · Centre for Chronic Disease Control, India (2) · Auris Medical AG (1) · Clinique Saint-Vincent (1)

What is being tested here

Drugs under test in Ear Diseases studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Aprepitant101
Sodium thiosulfate101
Mannitol101
Brimapitide022
Ciprofloxacin002
Dexamethasone011
Sustained-Exposure Dexamethasone Formulation OTO-104011
Ancrod001
Acetylcysteine001

Coming up

0phase 3 studies under way
6studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 6

Who these studies take

Of the 6 Ear Diseases studies recruiting now, 6 (100%) set no upper age limit and 0 (0%) stop at 75 or younger. 0 (0%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 2 (33%) take healthy volunteers.

Recruiting studies that take each age, of 6
AgeWomenMen
100 (0%)0 (0%)
186 (100%)6 (100%)
306 (100%)6 (100%)
406 (100%)6 (100%)
506 (100%)6 (100%)
656 (100%)6 (100%)
756 (100%)6 (100%)
856 (100%)6 (100%)

Across all 48 studies, recruiting or not: 21% stop at 75 or younger and 15% at 65; 25% take children; 0% are for women only and 0% for men only; 17% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Ear Diseases studies take

Of 17 interventional studies with no phase under Ear Diseases, half reached primary completion within 23 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Interventional, no phase23 mo9–35 · 17 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

Studies

Recruiting first, then most recently updated. Showing 48 of 48. search them.